Lung Cancer Panel 3 EGFR ALK1 ROS1 MET
The Lung Cancer Panel 3 EGFR ALK1 ROS1 MET test is a comprehensive genetic analysis that plays a pivotal role in the diagnosis and management of lung cancer. This test is designed to detect mutations in key genes associated with lung cancer, allowing for targeted therapies that can significantly improve patient outcomes.
What the Test Measures
This test measures specific genetic mutations in tumor tissue, including:
- EGFR: Epidermal Growth Factor Receptor
- ALK1: Anaplastic Lymphoma Kinase
- ROS1: ROS Proto-Oncogene 1
- MET: MET Proto-Oncogene, Receptor Tyrosine Kinase
Who Should Consider This Test
This test is recommended for individuals who:
- Show symptoms of lung cancer such as persistent cough, chest pain, or unexplained weight loss.
- Have a family history of lung cancer.
- Are current or former smokers.
Benefits of Taking the Test
By undergoing the Lung Cancer Panel 3 test, patients can:
- Receive a precise diagnosis to guide treatment decisions.
- Identify specific mutations that may respond to targeted therapies.
- Enhance communication with healthcare providers about treatment options.
Understanding Your Results
Results are typically available within 5-7 days. A healthcare professional will interpret the findings, explaining whether any mutations were detected and what that means for your treatment options.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 60,000 KSh | 80,000 KSh |
To book the Lung Cancer Panel 3 EGFR ALK1 ROS1 MET test, please contact us at +254746849631. We have branches across Kenya and offer home sample collection services for your convenience.
Note: A doctor’s prescription is required for this test, except in cases of surgery, pregnancy, or if you are planning to travel abroad.
